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Abstract
Prescription stimulants have been identified as one of the most written psychoactive prescription
medications found among college students. Likewise, prescription stimulant abuse (PSA) has
greatly increased in the college campuses (5.4% in 2003 to 9.3% in 2013). Several factors such
as (a) diversion and sharing of prescribed stimulants among families, friends and others; (b) lack
of knowledge about the risks associated with prescription stimulants; (c) polysubstance use; (c)
academic enhancement; and (d) stress from ineffective coping skills and life events, have been
identified as contributing factors to the increase in PSA among college students. Various critical
health-related symptoms such as tachycardia, hypertension, hallucinations, loss of concentrations
and depression have been identified with PSA. College students with prescription stimulants
need to be aware of the associated risks identified with prescription stimulants. In addition,
healthcare providers caring for college students who necessitate prescription stimulants need to
be familiar with substance abuse prevention efforts to manage PSA. Although, numerous
interventions have been implemented to reduce prescription drug abuse in general. However,
there is lack of evidence-based recommendations for the management of PSA among college
students. Therefore, the purpose of this project was to develop evidenced-based
recommendations for healthcare providers to manage PSA among college students.
Recommendations were developed after a comprehensive literature review. Based on the
evidences retrieved from the reviewed literature: increase in awareness and education pertaining
to prescription stimulant, collaboration approach between healthcare providers, community,
family and development of spiritual competence have been suggested for healthcare providers
caring for college students with prescription stimulant. In addition, healthcare providers are
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encouraged to utilize these recommendations as a guiding tool when caring for college students
with ADHD or with potential for prescription stimulant abuse.

III

Table Of Contents
Abstract ......................................................................................................................................................... II
Acknowledgment ......................................................................................................................................... VI
Chapter 1: Introduction and Literature Review ............................................................................................ 1
Chapter 2: Concept Analysis ...................................................................................................................... 17
Chapter 3: Methodology and Framework ................................................................................................... 25
Chapter 4: Results ....................................................................................................................................... 32
Chapter 5: Discussion ................................................................................................................................. 59
References ................................................................................................................................................... 60

IV

List of Figures and Tables
Figure 1: Seven Steps of Iowa Model of Evidence-Based Practice (EBP) ................................. 25
Table 1:Hierarchy for Grading Data ........................................................................................... 29
Figure 2: Article Selection Process ............................................................................................. 33
Table 2:Summary of Results from the Selected Articles ............................................................ 34
Table 3:Summary: Levels of Evidence ....................................................................................... 51

V

Acknowledgment
First and foremost, all glory and honor belong to God, my heavenly father for given me the
opportunity and grace to start and complete this research project (Thank you Jesus: I couldn't
have done it without you!). I also give all praises to God for blessing me with a wonderful
husband and children (Manny and Bethany) who continually encourage and support me
physically, spiritually and psychologically (I couldn't have done this without you and I love you
very much guys!). I will like to acknowledge Dr. Waker from the Center for Nursing Excellence
education at Kettering Health Network for her research-expert advice provided especially at the
beginning of this project; my advisor Marsha Swinehart MSN, RN, CNE for her spiritual
presence and advice; my committee members: Elizabeth Delaney MS, RN, CNS, FNP-BC,
OCN, ACHPN (for her spiritual support and belief in me (thank you sister!); Clifford Fawcett
M.S.N., M.Ed., RN, CFNP (thank you for neutralizing the pressure!). I would also like to
acknowledge my committee chair Dr. Chu-Yu Huang RN, PhD who stood by me in every way
and constantly belief that I could even do this project (You are amazing! thank you).

VI

Chapter 1: Introduction and Literature Review
Introduction
The prevalence in prescription stimulants for nonmedical use among college students has
rapidly increased since 2003 (from 5.4% in 2003 to 9.3% in 2013) (Cutler, 2014; McCabe, West,
Teter et al., 2014; Teter, McCabe, LaGrange, Cranford, & Boyd, 2006). Stimulants have been
identified as one of the main written psychoactive prescriptions among college students (4% in
1991 to 45% in 2010) (McCabe, West, Teter et al., 2014; Teter, Mcabe et al., 2005). The
increase in PSA among college students have been associated with several critical health-related
adverse effects (Buckstein, 2014: Substance Abuse and Mental Health Services Administration:
SAMHSA, 2014: Helseth, Lykke-Enger, Johnsen, & Waal, 2009). Examples of contributing
factors to PSA among college students are diversion and sharing with friends, family and others,
lack of awareness of the dangers involving prescription stimulant, polysubstance use and stress
(Barrett, Darredeau, Pihl, 2006; Herman, Shtayermman, Aksnes, Anzalone, Cormerais, &
Liodice, 2011; McCabe, Teter, Boyd, 2006). However, there is a lack of evidence-based
recommendations for managing PSA among college students. Therefore, the purpose of this
project was to develop evidenced-based recommendations for healthcare providers to manage
PSA among college students.
Literature Review
Several studies have shown stimulants such as Amphetamine-dextroamphetamine
combination agent (Adderall) and Methylphenidate (Ritalin) as one of the most written
psychoactive prescriptions among college students (Arria & Dupont, 2010; Baldwin, Johnson,
Gotz, Wayment & Elwell, 2006; Herman et al., 2011; McCabe, West, Teter et al, 2014; Weyandt
et al., 2014). The overall rate at which stimulants are prescribed for young adults in the United
1

States increased from 4% in 1991 to 45% in 2010 (Akici et al., 2013; Arria &Dupont,
2010; Drug Abuse Warning Network (DAWN), 2011; National Institute of Drug Abuse (NIDA),
2012; World Drug Report, 2014). The result of a drug use study from a national perspective
revealed that over one million prescription stimulants was issued to over fifty-four thousand
persons in Denmark between 1 January1995 and 30 September 2011 (Pottegård, Bjerregaard,
Glintborg, Kortegaard, Hallas, & Moreno, 2013). Likewise, the estimated lifetime and past- year
prevalence of nonmedical use of prescription stimulants increased significantly between 2003
and 2013. McCabe, West, Teter et al. (2014) found that the past year illegal use of stimulants
among college students has significantly increased from 5.4% in 2003 to 9.3% in 2013
(p<0.001). On the contrary, the estimated lifetime and past-year occurrence of nonmedical use
of prescription opioids has considerably decreased over time (9.3% in 2003 to 4.5% in 2013)
(McCabe, West, Teter et al., 2014). In addition, DeSantis, Noar, & Webb (2010) reported
between 4.1% to 35.5% variability in the rate of prescription stimulant use among college
students. The survey conducted by Herman and colleagues (2011) reveals that about 10.4% of
the medical and health profession students have either used stimulants or are currently engaging
in an illegal use of prescription stimulants. In fact, the national survey result from monitoring
the future revealed Adderall as the most use of prescription stimulants among college students
(Johnston, O'Malley & Bachman, 2013). The results showed “Adderall was used more than
three times as many college students (10.7%) as was Ritalin (3.6%) in 2013” (p.380).
Furthermore, amphetamine use among college students has increased from 5.7% in 2008 to
11.1% in 2011 (Johnston et al., 2013). Although, a slight decrease was noted in 2013 (10.6%),
the percentage continues to place college students in the highest of prescription stimulants use
for improving academic performance than 12th graders (6.6%) (Johnston et al., 2013).
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Factors Contributing to PSA
There are various factors reported to have contributed to the prevalence of PSA among
college students. The following three key contributing factors will be discussed in this literature
review: diversion and sharing of prescription stimulants, lack of awareness of the dangers of
prescription stimulants, and stress resulting from changes in life events.
Diversion and sharing. The increase in prescription stimulants for medical use has been
reported to have concomitantly augmented the increase in prescription stimulant for nonmedical
use (American College Health Association, 2014; Barrett, Darredeau, Bordy, & Pihl, 2005;
Baldwin et al, 2006; Gomes, Song, Godwin, & Toriello, 2011; Hauer, 2010; Judson & Langdon,
2009; Low & Gendaszek, 2002; McCabe, Knight, Teter, & Wechsler, 2005; McCabe, West Teter
et al., 2014). The increase in percentage of prescription stimulants for medical use such as to
treat the symptoms of attention-deficit hyperactivity disorder (ADHD) in college students
increases from 1.9% in 2003 to 4.7% in 2013. Concurrently, the percentage of nonmedical use
of prescription stimulants such as the diversion of the prescribed stimulants to friends and family
appears to have increased from 5.4% in 2003 to 9.3% in 2014 (McCabe, West, Teter et al.,
2014). McCabe, West, Teter et al. (2014) reported the following findings from the College
Student Life Survey (CSLS) conducted in the winter semester of 2003 through 2013 among
undergraduate population of full time college students of a public research university:
•

Prescription stimulants are the most diverted and shared prescription medication among
college students.

•

There is increase in prescription stimulants and prescription stimulants diversion (selling,
trading, or giving away) among college students.
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•

About 54-percent undergraduate students with prescription stimulants for medical use
have shared, sold or gave away the prescribed stimulants to family or friends.

While the CSLS result revealed a decrease in diversion rate of stimulants from 53.0% to
46.2%, the percentage that represents the decrease in diversion rate of prescription stimulants
(46.2%) is higher than the percentage that represents diversion rate of other psychoactive drugs
such as “sleeping medication” (18.9%), “sedative or anxiety medication” (22.2%), “pain
medication” (14.4%) ( McCabe,West et al., 2014). Moreover, the opportunity for being offered
prescription stimulants and PSA have been associated with age and year spent in the college
campus (DeSantis, Noar et al., 2010). A study by Garnier-Dykstra, Caldeira, Vincent, O’Grady
& Arria (2012) also showed the opportunity for being offered prescription stimulant and PSA
increases from 36.0% in the first year in college to about two-thirds (61.8-percent) by the end of
forth year in college. This result shows (a) there is a chance of being exposed to prescription
stimulants in the college campuses; (b) college students with prescription stimulants have a habit
of sharing or diverting their prescription stimulants to friends and others without the
authorization of their healthcare providers and; (c) college students who are being offered
prescription stimulants have tendency to abuse or misuse the prescription stimulants.
Lack of awareness concerning the dangers of prescription stimulants. According to
Kuhar (2014), prescription stimulants have been accepted as non-dangerous as long as they are
dispensed as ordered, used as prescribed, and closely monitored by licensed professionals.
Several research articles have described methylphenidate (MPH) and amphetamines as highly
effective pharmacological management of ADHD (Baldwin et al., 2006; Barrett, Darredeau,
Bordy et al., 2005; Bukstein, 2014; Cutler, 2014; Judson & Langdon, 2009; Low & Gendaszek,
2002; Mészáros, Czobor, Bálint, Komlósi, Simon, & Bitter, 2009; Teter, McCabe, Cranford,
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Boyd, & Guthrie, 2005; McCabe, Knight, Teter et al, 2005; McCabe, Teter, Boyd et al., 2006;
Weyandt et al. 2014). Furthermore, the high effectiveness of prescription stimulants in the
management of ADHD has made them acceptable as the first line pharmacological agents for
treating the symptoms of ADHD (American College Health Association, 2014; Baverstock &
Finlay, 2003; Bukstein, 2014; Cutler, 2014; Krull, 2014; Weyandt, et al., 2014). A meta-analysis
of six short-term clinical trials comparing stimulant medication with placebo in adults with
ADHD shows patients receiving the stimulant experienced greater improvement in ADHD
symptoms compared with placebo, with an estimated effect size in the medium-to-high range
(Cohen’s d = 0.67, p<0.0001 vs. placebo) (Mészáros et al., 2009). Therefore, the United States
Food and Drug Administration (FDA) has approved the efficacy of stimulant medication for the
treatment of ADHD (Spencer, Biederman, Wilens, 1998 as cited in Weyandt et al., 2014).
Furthermore, several studies have disclosed most college students who abuse prescription
stimulants perceived stimulants to be more appropriate than the street drugs because they are
usually prescribed by licensed professionals (DeSantis, Noar et al., 2010; Cutler, 2014; Gomes et
al., 2011; McCabe et al., 2008; Teter, McCabe et al., 2005). Cutler (2014) reported college
students’ perception of prescription stimulants “as opposed to illegal stimulants (such as cocaine
and methamphetamine) as “safer” choices for experimentation and getting high because they
have been approved by the Food and Drug Administration (FDA) and are “pure,” having known
chemical compositions and predictable side effects” (p.278). The result of the semi-structured
interviews conducted between 2010 and 2011 academic year among seventy-six college students
from a large, public northwestern university documented ‘safety’ as one of the major reasons for
PSA among college students (Cutler, 2014). In addition, the study conducted by Arria, Caldeira,
Vincent, O’Grady & Wish (2008) also revealed one out of four students perceived increased risk
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of harm from occasional PSA (25.2%). Therefore, high perceived harmfulness was associated
with lower PSA (p < 0.05). These scholars revealed individuals who perceived “no risk” in PSA
as the most likely to use stimulants (b=3.4, p<0.01), followed by those whose perceived risk was
“slight” (b=2.8, p<0.01) or “moderate” (b=0.9, p=0.11).
On the other hand, stimulants are recognized as potentially addictive chemical substances
(Barrett, Darredeau, Bordy et al., 2005; Bukstein, 2014). The addictive characteristics of CNS
stimulants may lead to dependency that could ultimately affect the overall wellbeing of a person
including the mental, emotional, physical, occupational, intellectual, and spiritual aspects (Chen,
2006; Chidarikire, 2012; Helseth, Lykke-Enger, Johnsen, & Waal, 2009; SAMHSA, 2013).
Moreover, the rate of addiction or dependency among individuals with medical use for ADHD
treatment has not been well established (Bukstein, 2014). However, the later the age of initiation
of prescription stimulant the lower the tendency for prescription stimulant addiction. Individuals
who started using prescription medication at age 13 were found to have developed prescription
drug abuse and dependence versus those individuals who began using at or after 21 years of age
(McCabe, West, Morales, Cranford, & Boyd (2007). The probabilities of developing any lifetime
prescription drug abuse among non-medical users was reduced by approximately 5% with each
year the non-medical use was delayed (McCabe, West, Morales et al., 2007). In addition, the
effects of prescription stimulants abuse on the cardiovascular system remain controversial. For
example, Habel et al. (2011) research study showed no associated risk of prescription stimulants
on the cardiovascular system among young and middle-aged adults. A non-randomized cohort
study conducted among 18 years and older with methylphenidate prescription revealed a lack of
a dose-response relationship (Schelleman et al., 2012). The result of the study revealed the agestandardized incidence rate per 1,000 person-years of sudden death or ventricular arrhythmia was
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2.17 (95% CI=1.63-2.83) in methylphenidate users and 0.98 (95% CI=0.89-1.08) in nonusers, for
an adjusted hazard ratio of 1.84 (95% CI=1.33-2.55) (2012). This result showed the dose of
methylphenidate is inversely related to the risk experienced by an individual. For this reason, the
authors concluded there may be no causal relationship between methylphenidate and
cardiovascular side effects. Even if a 1.8 fold increase in the risk of sudden death or ventricular
arrhythmia was reported in young and middle adult at the initiation of methylphenidate
(Schelleman et al., 2012). Similarly, some studies have reported prescription stimulant use
without the supervision of licensed health care providers is associated with cardiovascular,
psychological, spiritual, and mental adverse effects such as cardiac arrhythmias, tachycardia,
hypertension, syncope, hopelessness, psychosis, depression (Bukstein, 2014; Helseth, LykkeEnger, Johnsen & Waal, 2009; McCabe, & Teter, 2007; NIDA, 2012; Ruwald, Ruwald, &
Tønder, 2012; SAMHSA, 2013; Schelleman et al., 2012; Stiefel & Besag, 2010 as cited in
Martinez-Raga, Knecht, Szerman, & Martinez, 2013; Teter, Falone, Cranford, Boyd, & McCabe,
2010;Volkow, 2010. The meta- analysis randomized clinical trials conducted by Castells, Cunill,
Capellà (2013) showed the use of methylphenidate for the treatment of ADHD symptoms was
discontinued among ten percent adult because of the adverse effects experienced during
treatment. Other identified mild to moderate adverse effects associated with prescription
stimulants are dry mouth, insomnia, restlessness, irritability, dysphoria, loss of appetite, weight
loss, depression, headaches and potential for sudden cardiac death (Bukstein, 2014; Castells et
al., 2013; Martinez-Raga et al., 20I3; Teter, Falone et al., 2010). Depressed moods have been
recognized in about 30 percent college students who frequently abuse prescription stimulants
(Teter, Falone et al., 2010). Some other identified side effects are the exacerbation of existing
motor and vocal tics as well as new onset of tics, amphetamine-induced psychosis, and
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schizophrenia disorder (Bukstein, 2014; Bramness, et al., 2012). Therefore, prescription
stimulant is not safe because they have a potential addictive effects and the addictive
characteristics may potentially affect the overall well-being and lead to sudden death
Additionally, Baldwin and colleagues (2006) conducted a needs/assets assessment survey
on college campuses using six focus groups, with a total of 45 undergraduate college students
from various majors. The college students generated a list of 25 substances used in the college
campuses and reported to divert these drugs for nonmedical uses. The report of this survey also
revealed college students fake medical conditions to obtain prescription for methylphenidate or
other prescription stimulants for the following reasons such as for recreational use, mixing with
alcohol to achieve “high” and for financial purpose. The results of the survey also indicated that
the students were not adequately educated on the adverse effects associated with the prescription
stimulants abuse. At the same time, the researchers discovered that the healthcare providers in
the college campuses were not cognizant of the variety of substances used among students and
the ways the students obtain these substances. These results not only highlight the importance of
further education to raise awareness, but also stress the value of team approach (students, faculty
and health-care providers) in preventing substance abuse in college campuses.
Moreover, some studies have shown the relationship between prescription stimulant
abuse and other controlled substances such as alcohol and other psychoactive drugs (Arria et al.,
2008; Arria & Dupont, 2010; Barrett, Darredeau, Bordy et al., 2005; Barrett, Darredeau Pihl,
2006; DeSantis, Noar et al., 2010; Johnston et al., 2013; Judson & Langdon, 2009; McCabe,
Knight, Teter et al., 2005; ; McCabe, Teter, Boyd et al, 2006; McCabe, West, Morales,
Cranford, & Boyd, 2007; McCabe, West, Teter et al, 2014; Teter, McCabe et al., 2005). The
result of Barrett and colleagues’ (2006) study showed “those who misused MPH were more
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likely to have used various other prescriptions and nonprescription stimulant drugs over their
lifetimes.” In this study, those who abuse MPH agreed to recreationally utilize other variety of
substances during their lifetimes (mean 7.7, SD 3.0) relative to control subjects (mean 3.8, SD
3.1) {t = 5.98, df 98, P < 0.001). Moreover, the Chi-square tests also showed that MPH users
were more likely to report recreational use of ecstasy, cocaine, ephedrine, d-amphetamine, and
psilocybin (all Ps < 0.001) than were control subjects (Barrett 2005. P. 458). These results show
that college students are not fully aware of the danger of the use of prescription stimulants
including potential for poly-substance abuse.
Stress. Another factor identified with the increase in PSA among college students is stress
(Herman et al., 2011). Freshmen college students face challenges from new responsibilities, new
curriculum, and higher expectations that are different from high school settings (Herman et al.,
2011; Teter, Falone et al., 2010). The workload of college, meeting deadlines, keeping up with
social lives, and waiting to the end of the semesters to study for final examinations are some of
the stressors identified with college students (Macan, Shahani, Dipboye, & Phillips, 1990;
Alzayyat, & Al-Gamal, 2014). The fear of failure and anxiety as a result of change in curriculum
reported among college students are encouraging prescription stimulant abuse (Desantis, Noar et
al, 2010; Garnier-Dykstra et al., 2012; Gomes et al., 2011; Teter, Falone et al., 2010). However,
college students who are able to cope effectively and manage their new environment with change
in academic and social lifestyles have shown improvement in academic performances (Forbus,
John, & Sanjay, 2010; Kearns & Gardiner, 2007; Macan et al., 1990). DeSantis, Webb, & Noar
(2008), survey shows most students who are unable to cope with the workload of college use
stimulants for academic performance enhancement. Most college students reported the reason
for engaging in prescription stimulant was to improve their grade point average (GPA) (a
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measure of academic performances) (Garnier-Dykstra et al., 2012). DeSantis, Webb et al. (2008)
study also revealed about 65-percent of students using Adderall to enhance concentrations, 59.8
percent students use Adderall to study, and 47.5-percent use Adderall for increase alertness to
study longer. Among all the motives, studying was identified by most college students as the
predominant purpose of engaging in prescription stimulant abuse (73-percent to 91.5-percent
annually) (Garnier-Dykstra et al., 2012).
On the contrary, the use of prescription stimulant has been reported to have no
relationship with increasing the GPA. Those who abuse prescription stimulants have been
reported to have lower GPAs when compared to non-users (DeSantis, Noar et al., 2010). The
result of the questionnaires administered by Advokat, Lane, & Luo (2011) to a total of 92
students with a self-reported diagnosis of ADHD who use prescription stimulants for ADHD
symptoms management was compared with 143 controlled students in a survey of academic
performance. The result showed the GPA of the ADHD students who took the medications was
still significantly lower than the control group GPA (p = .022). McCabe, Knight, Teter et al.
(2005) mail survey result also showed students who received a B or lower GPA were almost two
times more likely to report prescription stimulant abuse (5.2% (95% CI= 4.2, 6.5) compared to
students who earned a B+ or higher (3.3% ( 95% CI= 2.6, 4.1).
Interventions For Decreasing Substance Abuse Among College Students
The risk for polysubstance use increases among college students who engage in any kind
of substance abuse (Barrett, Darredeau, Pihl, 2006; DeSantis, Noar et al., 2010; Johnston et al.,
2013; Teter, McCabe et al., 2005; NIDA, 1995). Therefore, most interventions are specifically
developed to address substance abuse in general. These interventions can be grouped into three
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categories such as the ecological, or environmental approach, the group-centered approach, and
the individual-centered approach (Baldwin et al., 2006).
The ecological or environmental approaches. These approaches focus on the
institution, community and public policy level in relation to physical and social environment
(Baldwin et al., 2006; DeJong, Gomberg, Towvim, & Schneider, 2007; Kann, Telljohann, &
Wooley, 2007). The ecological approaches proposed that young people’s decision to abuse a
substance is fashioned by a “complex combinations of physical, social, economic, and legal
factors.” These combinations also have a great impact on the substance’s demand and
accessibility (DeJong ett al., 2007, p.231). Therefore, the objective of these preventive strategies
is to adjust the physical and social environment in the reduction of substance abuse in the
community including college campuses. For example, DeJong and the colleagues (2007)
developed 12 policies and enforcement strategies to reduce alcohol problems on campuses. The
researchers used a random sample of 9,600 students from 32 four-year colleges and universities.
A voluntary, anonymous email survey was administered to assess the students’ alcohol-related
attitudes, perceptions, behaviors and their supports for the alcohol policies and enforcement
strategies. The results showed that the majority of the students at all 32 schools supported
stricter enforcement policies and penalties to maintain a safe and substance-free campus. Saltz
and DeJong (2002) also concluded that modifying the environment through institution,
community, and public policy changes are the most resource-efficient way of reducing substance
abuse problems.
Furthermore, several studies have shown the effectiveness of school-based intervention
programs on prevention of substance abuse among students. For example, programs which
facilitate (a) growth awareness and resistance skills such as messages from media, normative
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education, resistance to peer influences, and emphasis on healthy behavior; (b) personal efficacy
and social skills such as decision-making, coping and stress management, and communication;
and (c) effective components such as improving self-esteem have demonstrated positive effects
in reducing the amount of illegal drug found among students (Champion, Newton, Barrett, &
Teesson, 2013; Kann, Telljohann, & Wooley, 2007 as cited in Kumar, O'Malley, Johnston, &
Laetz, 2013). In general, these approaches empowered students, staff, and faculty with
leadership skills to promote policies and plans against all kinds of substance abuse, permit
students to embrace positive values and promote a beter social interaction among students and
faculty (Bucknam, 1994; DeJong et al., 2007).
The group-centered approaches. The objectives of the group-centered approaches in
the prevention of substance abuse focus on the relationship between students and their
perceptions concerning drinking standards on college campuses (DeJong & Langford, 2002).
These approaches allow for strategic planning of different levels of interventions to specifically
reduce the abuse of alcohol among college students (DeJong et al., 2002). One of the
interventions suggested is the implementation of social norms campaign. Social norms is viewed
as perceiving a certain behavior such as the episodic drinking in the college campuses as normal
(Moreira, Smith & Foxcroft, 2009). A study by Matten & Neighbours (2005) revealed a
correlation between promotions of social norms campaigns and changes in perceived drinking
norms. The paired samples t-tests of the study disclosed a reduction in perceptions of individual
college student drinking occurrence and amount. The result of the study shows a reduction in the
drinking level of alcohol when the idea surrounding drinking in the colege campuses was
promoted as abnormal and unacceptable. However, the reduction in drinking level was noticed
only among the students who perceived episodic drinking was normal in the college campus.

12

The implementation of social norms has shown a changing effect on students’ perceptions of
drinking norms which reduces levels of drinking among college students (Matten et al., 2004).
The individual-centered approaches. These approaches include a brief intervention
(BI)/ brief motivational intervention (BMI), feedback, provider screening, and mailed feedback
on the possible consequences related to substance abuse (Baldwin et al., 2006; Fachini, Aliane,
Martinez & Furtado, 2012; Larimer & Cronce, 2007). The purpose of the individual-centered
approach is to provide education/awareness and early screening to detect alcohol abuse and its
related harmful consequences among college students (Fachini et al., 2012; Larimer et al. 2007).
For this reason, the approaches include early identification, education, prevention, treatment with
professional advice and feedback. The conclusion of the literature review on the effectiveness of
the individual-focused college drinking prevention strategies conducted from 1999-2006 by
Larimer and colleagues (2007) revealed BMI as effective method for the individual who wants to
quit or not yet dependent on a controlled substance. The individual-centered approaches also
were categorized as the information/knowledge programs and the brief motivational intervention
(BMI) programs.
The information/knowledge programs. The program provided “a pamphlet with
information about risks of drinking, in which participants recorded information about their
drinking to a wait-list control.” (Larimer et al. 2007, p. 2443). As an education/awareness
program, the overall conclusion of the information/knowledge programs revealed reductions in
number of drinks per week over time, and there was no reduction in heavy episodic drinking.
Hence, one out of ten reviewed research articles supported the information/knowledge programs.
The brief motivational intervention. The purpose of the BMI program is to reduce
extreme drinking by providing early screening and intervention to reduce the number of alcohol-
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related problems in the college campuses (Fachini et al., 2012). Several studies have revealed a
positive long-term effect on reduction of alcohol abuse among college students after several
years with BI/ BMI (Fachini et al., 2012; Larimer et al., 2007; Marlatt et al., 1998 as cited in
Baldwin, 2006). A systematic review and meta-analysis conducted by Fachini and colleagues
revealed the effectiveness of BI/BMI on college students with episodic drinking. The
motivational intervention delivered to these college students was based on the principles of the
Brief Alcohol Screening Intervention for College Student (BASICS) proocol. The BASICS
protocol includes using (a) techniques of motivational interview and personalized feedback
based on students drinking behavior; (b) delivering face-to-face intervention which is usually
conducted over the course of two structured sessions and (c) comparison with other conditions
(such as control group or alternative intervention) (Fachini et al. 2012, p. 2). The samples of the
college student ranged from 54 to 1275 (median=212). The review concluded students receiving
BASICS had a significant reduction in alcohol consumption (difference between means =−1.50
drinks per week, 95% CI: -3.24 to −0.29) and alcohol-related problems (difference between
means =−0.87, 95% CI: -1.58 to −0.20) after approximately 12-month of follow-up compared to
the control group. However, the efficiency of BMI/BI in reducing other drug-related abuse in
people not seeking help has not been well established (Hingson, & Compton, 2014; Young,
Stevens, Galipeau, Pirie, Garritty, Singh, & Moher, 2014; Saitz, Barrio, & Miquel, 2014). The
meta- analysis review also shows 10 out of 14 reviewed studies support BMI. Overall, brief
intervention for college students utiilizing the BASICS protocol and delivered face-to-face can
lower both alcohol consumption and negative consequences in college students.
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Problem Statement
The rate at which stimulants such as Amphetamine-dextroamphetamine combination
agent (Adderall) and Methylphenidate (Ritalin) are prescribed has rapidly increased (4% in 1991
to 45% in 2010) (Akici et al, 2013; NIDA, 2012; World Drug Report, 2014). The research
conducted by McCabe and colleagues in 2013 and Teter and colleagues in 2006 revealed
increase in prevalence of PSA among college students from 5.4% in 2003 to 9.3% in 2013. The
health related consequences associated with PSA are physical, psychological, spiritual and some
risks taking behaviors such as polysubstance abuse (American College Health Association, 2014;
NIDA, 2011; Arria & Dupont, 2010; Barrett, Darredeau, Bordy et al., 2005; Barrett, Darredeau,
Pihl, 2006; Becker & Starrels, 2014; Bukstein, 2014; Castells et al., 1013; Chen, 2005). While
several approaches have been implemented to manage substance abuse in general, there is lack
of evidence-based recommendation for managing PSA among college students. Therefore, the
purpose of this project was to develop evidence-based recommendations for managing PSA
among college students.
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Chapter 2: Concept Analysis
The concept analyzed in this chapter is prescription stimulant abuse. The method of
concept analysis by Walker & Avant (1985) was used for the analysis.
Definitions
Stimulants
Stimulants are one of the classes of psychoactive drugs that act to alter the activities in
the brain (Bukstein, 2014). According to Bukstein, stimulant ingestion increases the
“intrasynaptic concentrations of dopamine and norepinephrine” in the brain (2014). Dopamine
and norepinephrine are among the neurotransmitters found in the brain and assist in the
conduction of signals in the brain and other vital areas (Mandal, 2013; McCance & Huether,
2010.p. 448, 2010). These neurotransmitters act as “chemical messengers”. The effect of
dopamine and norepinephrine may be inhibitory or excitatory. The excitatory effects of synthetic
dopamine and norepinephrine in the brain stimulate the sympathetic nerves and may produce
some physiological symptoms such as tachycardia, hypertension, euphoria, jittering,
hyperglycemia, and restlessness (NIDA, 2014). The inhibitory effects of chemical messengers
on the parasympathetic nerves may slow down most activities of the body and result in
depression and drowsiness (Mandal, 2013; McCance et al, p. 448, 2010). In addition, stimulants
such as amphetamines (Adderall and Dexedrine) and MPH (Ritalin and Concerta) are classified
as one of the schedule II drugs. Schedule II drugs provide positive therapeutic effects, however,
they have a significant potential for abuse (DEA.Gov. 2005 & NIDA, 2006). Therefore, this
class of drugs may only be used if prescribed and signed by a licensed practitioner. A refill of
schedule II drugs is permitted only after the patient returns to the licensed practitioner for
additional assessment (Arcangelo & Peterson, 2013). Furthermore, stimulants are classified as
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long-acting with sustained release and short acting with immediate release (Bukstein, 2014). For
example, amphetamines are available in immediate and sustained-release formulations with an
onset of action of 20 to 60 minutes. The duration of methylphenidate’s clinical effect varies such
as short-acting (3 to 5 hours); intermediate-acting (4 to 8 hours); and long-acting (8 to 12 hours).
Moreover, the immediate-release formulation of mixed amphetamine salts has a duration of up to
six hours and the longer-acting formulations last up to 10 hours (Daughton & Kratochvil, 2009).
Prescription Stimulants
The word ‘prescription’ can be variously defined. However, the working definition
embraced for this project is from Aronson (2012). The research article by Aronson (2012)
defines prescription as an officially written instruction or message provided by a licensed
healthcare provider for a specific condition. In addition, the written instruction or message from
a licensed professional will be “ balanced” if it includes a detailed information of the medicine or
therapy, the form, frequency, dosage, route, and to whom the medication or therapy will be given
(Aronson, 2009 & Aronson, 2012). Prescription stimulants used as prescribed by a licensed
health care practitioner for managing specific symptoms are simultaneously referred to as
medical use prescription stimulants (MUPS) (Teter, McCabe et al., 2005). Therefore, a
prescription stimulants is referred to as “balanced” prescription when it contains information
provided by a licensed healthcare practitioner, for a patient’s appropriate condition(s) and also
within the therapeutic goal to provide more benefits than harm the patient (Aronson, 2009 &
Aronson, 2012).
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Prescription Stimulant Abuse (PSA)
PSA is defined as unlawful use of prescription stimulants by an individual in a way that is
not prescribed or authorized by a licensed care practitioner (Cutler, 2014; DAWN, 2011;
Greydanus, 2014; McCabe et al, 2006; NIDA, 2014; Teter, McCabe et al., 2007, Barrett et al.,
2006; Volkow & Swanson, 2003; Volkow, 2010). The unlawful way of obtaining and using
prescription stimulants or PSA are also refer to as a “nonmedical use” of stimulants (NMUPS)
(Baldwin et al., 2006; Barrett et al., 2006; Cutler, 2014; McCabe, Knight, Teter et al., 2005;
McCabe et al, 2006; NIDA, 2014; Teter, McCabe et al., 2005; Rozenbroek & Rothstein, 2003).
The use of prescription stimulants for an enjoyable effect such as recreational use in abundant
quantities and getting ‘high’ is referred to as PSA or nonmedical use (Barrett et al., 2006). The
nonmedical users of prescription stimulants have been also known to use prescription stimulants
via intranasal, smoking on inhalation and or intravenous (Teter, McCabe et al., 2005; Barrett et
al., 2006). Therefore, the prescription stimulants use in another way or route other than indicated
by a licensed practitioner is characterized as PSA
Defining Attributes of PSA
The defining attributes of PSA are:
‘Unauthorized Use’
The prescription stimulants (long or short acting) which are being used other than for the
right patient, dose, frequency, route are viewed as unauthorized use (Aronson, 2009; Aronson,
2012; Bukstein, 2014; Gunter, 2013; Judson et al., 2009; Weyandt, et al, 2014).
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Diversion or Sharing
The prescription stimulants that are diverted or shared with friends, family or others are
also characterized as PSA (Ellis & Mullan, 2009; Barrett et al., 2006; Garnier-Dykstra, 2012).
The primary source of MPH abuse has been identified as through diversion from friends or
family with MUPS (Barriett, et al., 2006; McCabe, West, Teter et al., 2014; Garnier-Dykstra,
2012).
Antecedents To PSA
The Increase In The Prescription Of Stimulant And Diversion
Most PSA occurs as a result of the increase in the availability of stimulants through
written prescription and diversion to friends, family and others (American College Health
Association, 2014; Barrett et al., 2005; Baldwin et al, 2006). As discussed in previous chapters,
several studies have shown stimulants such as Amphetamine-dextroamphetamine combination
agent (Adderall) and Methylphenidate (Ritalin) as one of the most written psychoactive
prescriptions among college students (McCabe, West, Teter et al, 2014; Akici et al, 2013;
Baldwin et al., 2006; Herman et al., 2011; Weyandt, et al.., 2014). Likewise, the increase in the
prescription of stimulants among college students has paved the way for the increase in diversion
or sharing among college students.
Lack Of Awareness Of The Negative Impacts Of Prescription Stimulants
Other antecedents to PSA are lack of awareness of the negative impact of prescription
stimulants and stress (Barrett et al., 2006; Cutler, 2010; Garnier-Dykstra et al., 2012). Most
college students perceive prescription stimulants as safe because they are prescribed by licensed
healthcare practitioners. However, a study by Barrett and colleagues (2006) revealed the risk of
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simultaneous polysubstance use among drug-using college students. The result of the study
indicated that most students who recreationally utilize a controlled substance have the tendency
to engage in more than one substance such as alcohol and other psychoactive drugs (Barrett et
al., 2006).
Stress
The stressful event of college student life has been revealed to precipitate the increase of
PSA (DeSantis, Webb et al., 2008; McCabe, West, Teter et al., 2014). Most college students
(73%-91%) have identified studying for good grades as one of the most reasons that precipitated
the reason for their PSA (Garnier-Dykstra, et al., 2012).
Consequences Of PSA
The addictive characteristics of CNS stimulants may lead to dependency that could
ultimately affect the overall wellbeing which includes the “mental, emotional, physical,
occupational, intellectual, and spiritual aspects of a person's life.” (Bukstein, 2014; SAMHSA,
2013; Chen, 2006; Chidarikire, 2012; DeSantis, Webb et al., 2008). Studies have shown the
relationship between prescription stimulant abuse and other controlled substances such as
alcohol and other psychoactive drugs ( DeSantis, Webb et al., 2008; Barrett et al, 2005; Arria, et
al., 2008; McCabe, West, Teter et al, 2014; Johnston, O'Malley, & Bachman, 2013).
Prescription stimulants use without the supervision of licensed health care providers have been
associated with cardiovascular adverse effects such as cardiac arrhythmias and hypertension
(Ruwald, Ruwald, & Tønder, 2012 & Stiefel & Besag, 2010 as cited in Martinez-Raga, Knecht,
Szerman, & Martinez, 2013).
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Case Model
MK was a 19-year-old male and freshman college students. He came to the outpatient
clinic for a refill on his ADHD medication (Ritalin IR 30mg twice daily). Ritalin was prescribed
to MK 10 days ago, and the instruction was to have a 30 day supply from his pharmacy. MK
stated he had his 30-day supply but had increased his frequency of dosage from twice daily to as
needed. MK also stated using his medication more than three times daily due to the stressful
events surrounding his upcoming final examination.
After completing the history and physical examination, MK was discovered to have given
some of his prescribed medications to his roommate (SL) who knows MK’s health diagnosis.
MK stated SL told him he had read on the internet the efficacy of Ritalin (a stimulant) in
increasing concentration and time for study. MK stated he was not sure of how many of his
medication SL had taken but knew SL had been crushing and inhaling some medication. MK
also stated they both keep their medications in one medicine cabinet in the same bathroom he
shares with his roommate.
In this case model, MK demonstrated some attributes of PSA such as taking prescribed
stimulants not as authorized by his health care practitioner, using the wrong dose with the wrong
frequency and sharing his prescribed stimulant with his roommate. MK’s roommate (SL) also
demonstrated the attribute of PSA by utilizing prescription stimulant without authorization and
through the route not approved or recommended by a licensed healthcare practitioner.
Application To The Project
The importance of increasing awareness of PSA among college students and their
providers is critical to the management of PSA. College students with prescription stimulants
need to be aware of the associated risks identified with prescription stimulants. Similarly, health
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care providers caring for college students who necessitate prescription stimulants need to be
familiar with substance abuse prevention efforts to manage PSA. Evidence-based
recommendations for managing PSA can be used as a guiding tool for healthcare providers when
healthcare providers provide face-to-face consultation in the primary care settings to college
students with prescription stimulants. In addition, collaborating with family of the college
students with prescription stimulants and the community is very crucial to the management of
PSA. Therefore, the evidence-based recommendations generated from this project will be useful
also in reminding health care providers to involve the family of college students in the
management of their stimulant prescriptions.
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Chapter 3: Methodology and Framework
Methodology and Framework
The IOWA Model of Evidence- Based Practice (EBP) was used to guide this evidencebased project. The IOWA model provides a systematic approach to describing knowledge
transformation and to guide the implementation of research into clinical practice (Titler et al.,
2001). This model has shown effectiveness in improving health care outcomes internationally
across a variety of practice settings (Titler et al., 2001). Advanced practice nurses may use this
model to identify a significant clinical problem relevant to their clinical practice, develop
evidence-based solutions and implement the solutions to the practice setting.
Figure 1: Seven Steps of Iowa Model of Evidence-Based Practice (EBP)

by Doody & Doody, 2011.
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The Iowa Model of EPB involves seven steps 1) select a topic, 2) form a team, 3) retrieve
evidences, 4) grade evidences, 5) develop an evidence-based standard, 6) implement the
evidence-based standard, and 7) evaluate the implementation of the evidence-based standard.
However, this study will focus on steps one through five of the model. (See Figure 1 for Seven
Steps of the IOWA Model) (Doody & Doody, 2011; Titler et al., 2001). This project focuses
only on steps one through five.
Step One: Selection Of A Topic
The topic of this project was selected based on the concerns expressed by various
research articles regarding the increase in the occurrence of PSA especially among college
students’ populations (Barrett et al., 2006; Cutler, 2014; McCabe et al., 2006; McCabe, West
Teter al., 2014; SAMHSA, 2013; Teter, McCabe et al., 2005; Underhill & Langdon, 2013). As
one of the highest priority of public health concerns, prescription stimulants such as Adderall,
Vyvanse, concerta and Ritalin are reported as some of the most widely misused and abused than
opiods or other psychoactive prescriptions (McCabe, West. Teter et al., 2014: NIDA 2011:
Johnson et al., 2013). The number and percentage of persons aged 12 and older who currently
use methamphetamine increases in 2010 from 353,000 (0.1-percent) to 595, 000 (0.2-percent) in
2013 (SAMHSA, 2013). In addition, the result of the American College Health AssociationNational College Health Assessment (ACHA-NCHA II) released in the spring of 2014, reported
10.6-percent college male and 8.0-percent college female students using prescription stimulants
within the last 12 months (ACHA-NCHA II, 2014). In 2009, DAWN associated about 93, 562
emergency room visits with amphetamines and methamphetamine misuse (NIDA, 2011).
College students who lack awareness of the dangers surrounding the abuse of prescription
stimulant face several health consequences which can impact their total well beings. Based on
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this information, a close therapeutic monitoring of the prescription stimulant by healthcare
providers and comprehensive approach of management is essential to minimize the abuse of
prescription stimulants and reduce some health-related consequences (He, Sense, & Antshel,
2015; McCabe, West, Teter et al., 2014).
Step Two: Forming A Team
The team members include a MSN capstone committee (Cedarville University, School of
Nursing), and a healthcare provider from a local health network.
Step Three: Evidence Retrieval
This step involves retrieving related research evidences from educational databases to
support the project. The following stages were followed to retrieve evidences for this project:
Databases. Articles were retrieved from the following databases: Academic Search
Complete, Alt HealthWatch, AMED - The Allied and Complementary Medicine Database,
CINAHL Plus with Full Text, Cochrane Database of Systematic Reviews, Health SourceNursing/Academic Edition, MEDLINE with Full Text, New Testament Abstracts, Old
Testament Abstract, Psychology and Behavioral Sciences Collection, and PUBMED.
Key Terms. The following key terms used for retrieving articles from the databases are:
prescription stimulant abuse, nonmedical prescription use, prescription abuse, ADHD, stimulant
abuse intervention, stimulant abuse management, college health, substance abuse prevention,
substance abuse management, prescription stimulants, PSA prevention, young adults and college
students. Articles were not limited to full-text articles and the University’s holdings: InterLibrary Loan method was used to retrieve articles from other institutions for a comprehensive
literature reviews.
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Inclusion Criteria. The research articles were retrieved based on the following
inclusion criteria: 1) peer-reviewed research articles from the studies conducted in the United
States and from the international studies, 2) articles published in the last fifteen years with
exception of classic studies on PSA and substance abuse in general, 3) articles on PSA and other
substance abuse studies that use college students/young adults as the study participants, 4)
practice guidelines and position statements from professional organizations such as Agency for
Healthcare Research and Quality's (AHRQ) National Guideline Clearinghouse were included
this project.
Step Four And Five: Grading The Evidence and Developing EBP Recommendation
During this phase, articles were reviewed and organized. The strength of the research
findings was graded. For this project, Melnyk’s grading system was used to grade the strength of
research evidences, and the Joanna Briggs Institute (JBI) binary grading system of
recommendation was used to grade the evidence-base recommendations. The Melnyk grading
system (2011) consists of seven levels with level I being the strongest and level VII being the
weakest evidence. The grading system is presented below in table 1.
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Table 1:Hierarchy for Grading Data
Level I
Evidence from a systematic review or meta-analysis of all relevant
RCTs
Level II
Evidence obtained from well-designed RCTs
Level III
Level IV
Level V
Level VI
Level VII

Evidence obtained from well-designed controlled trials without
randomization
Evidence from well-designed case-control and cohort studies
Evidence from systematic reviews of descriptive and qualitative
studies
Evidence from single descriptive or qualitative studies
Evidence from the opinion of authorities and/or reports of expert
committees

Note. Adapted from Evidence-based practice in nursing and healthcare: A guide to best practice, by Melnyk, B.M.
& Fineout-Overholt, E., 2011, Philadelphia: Lippincott, Williams & Wilkins.

The JBI grading of the evidence-based recommendation enables easy interpretation and
implementation of the research evidences for both patients and clinicians into practice. The new
JBI grade of recommendation are adapted from the Grading of Recommendations Assessment,
Development and Evaluation also known as the GRADE approach (The Joanna Briggs Institute,
2014). The GRADE approach provides supervision to grading the quality of the primary
evidence and the strength of recommendations in health care (Brozek et al., 2009). Unlike the
level systems which classify findings based only on study design, the GRADE approach
classifies research findings based on other factors such as “critical appraisal/risk of bias,
publication bias, inconsistency, indirectness, and imprecision of evidence, effect size, doseresponse relationships, and confounders.” (The Joanna Briggs Institute, 2014, p. 3). Thereby,
randomized control trials study (Level I) may be ranked lower than a descriptive study (Level V
or VI) or expert opinions (Level VII) when and where applicable (Brozek et al., 2009; The
Joanna Briggs Institute, 2014).
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The GRADE approach was created by Grade Working Group in 2000 and used to assist
healthcare professionals with implementation of evidence into practice (Joanna Briggs Institute,
2014). The approach is now recognized by many evidence-based healthcare organizations such
as Cochrane, World Health organizations (WHO), Agency for Healthcare Research and Quality
(AHRQ), National Institute for Health and Care Excellence (NICE), British Medical Journal
(BMJ) amongst others (The Joanna Briggs Institute (2014). Furthermore, the GRADE
recommendation approach suggested some vital factors such as the “balance between desirable
and undesirable effects, the quality of the evidence, values and preferences, and costs” while
developing recommendations (The Joanna Briggs Institute, 2014, p. 7). The latest JBI binary
grading system of recommendations adapted from GRADE contains two grading options: A
“Strong” or “Weak” grade of recommendations with grade A being the strong recommendation,
and Grade B representing a weak recommendation.
Step Six: Implementation Of The Evidence-Based Standard
Based on the graded and the quality of the evidence, the recommendation emanated from
these research evidences will be incorporated into the clinical practices according to clinical
protocols and guidelines. Officials from a local health network and the staff manager of a
university student health center had expressed interested in this evidence-based
recommendations.
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Step Seven: Evaluation
The seventh step of the IOWA EBP involves evaluation of the research evidence for
success and possible modification. This phase also includes follow-up process to verify the
efficacy of the evidence-based recommendation.
Ethical Considerations
This project is exempted from the Cedarville University IRB since there is no potential
harm involved.
Committee Members
The committee consists of two members and one professional consultant:
•

Chu-Yu Huang, RN, PhD (Chair)

•

Elizabeth Delaney, MS, RN, CNS, FNP-BC, OCN, ACHPN (committee member)

•

Cliff Fawcett, M.S.N., M.Ed., RN, CFNP (professional consultant)
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Chapter 4: Results
Twenty-six articles were used to develop evidence-based recommendations for this
project. There were thirty six articles that met the inclusion criteria for this research project. Ten
of the thirty six articles were excluded from the analysis due to the use of study participants from
mixed age groups (such as a mix of middle school, high school and college students or
adolescents with college populations and young adults) and limited evidence for managing
prescription stimulants abuse. However, two longitudinal study with mixed participants was
retained for this project. One of the longitudinal studies was designed as a randomized
controlled trial. However, both longitudinal studies provided descriptions of the effect of
prescription drug abuse interventions introduced during adolescents on future initiation of
substance abuse.
The article selection process is presented in Figure 2. Table 2 presents a summary of the
results from the 26 articles.
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Figure 2: Article Selection Process
Screening

36 Articles met
inclusion
criteria

10 Articles removed due to
mixed populations such as:
• middle school, high
school and college
students
• Adolescents
populations with
college students and
young adults

Exclusion

Eligibility

26 Articles Eligible
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Table 2:Summary of Results from the Selected Articles
Authors & Year
published
Agency for
Healthcare
Research and
Quality (2013)

Research Titles

Design

Results

Attention deficit
hyperactivity
disorder.
Diagnosis and
management of
ADHD in
children, young
people, and
adults.

Systematic
Review

People with ADHD require integrated
care that addresses a wide range of
personal, social, educational, and
occupational needs.

Level of
Evidence
Level I

Care should be provided by
adequately trained healthcare and
educated professionals.
ADHD with prescription stimulants
need supervision

Amaro (2010)

Brief Screening
and Intervention
for Alcohol and
Drug Use in a
College Student
Health Clinic:
Feasibility,
Implementation,
and Outcomes.

Descriptive
Study

Drinking and drug use decreased
between baseline and 6 month after
Brief Alcohol Screening Intervention
for College Student (BASICS)
program
Alcohol use past 6 months before
intervention:
Baseline: 98.4%;
6–months follow-up after
intervention: 93.1%
Chi-square value 14.3; p value
(.0002)
Heavy Episodic drinking past 6
month before intervention:
Baseline: 67.2%
6-months follow-up after
intervention: 50.3%
Chi-square: 77.1; p<.0001
Illicit drug use, past 6 months before
intervention
Baseline: 56.1%
6-months follow-up after
intervention: 51.0%
Chi-square: 190.1: p <.0001
Illegal use of prescription drugs
(any), before intervention
Baseline past 6 months before
intervention 19.6%
6-months follow-up after
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Level VI

intervention 16.9%
Chi-square: 116.9 P<.0001
At 6-month follow-up, college
students reported decreases in the
quantity and frequency of weekly
episodic drinking (67% to 50%),
decreases in alcohol or drug-use
related distress and consequences,
and reductions in illicit drug and
prescription use.
American
College Health,
(2007)

Stimulant
Misuse :
Strategies to
Manage a
Growing
Problem

Expert opinion

Recognize the existence of this
problem; survey one’s campus
environment

Level VII

Cooperation of university officials,
health clinicians, college pharmacies,
and local law enforcement officials
Limit availability and access to
prescription stimulants
Educate high school and college
students regarding the dangers of
stimulant abuse

Arria, Caldeira,
Vincent, Grady,
& Wish (2008).

Perceived
Harmfulness
Predicts
Nonmedical Use
of Prescription
Drugs Among
College
Students:
Interactions
with SensationSeeking

A Longitudinal
Descriptive
Correlational
Study

Recognize signs of stimulant misuse
and abuse and provide management
options
High perceived harmfulness of PSA
is associated with lower prevalence of
nonmedical use of prescription
stimulant use at all levels of
sensation-seeking (p< 0.05).
Individuals who perceived “no risk”
in PSA were the most likely to use
stimulants (b=3.4, p<0.01), followed
by those whose perceived risk was
“slight” (b=2.8, p<0.01) or
“moderate” (b=0.9, p=0.11).

Increasing perceived harmfulness
may be a viable prevention strategy
for most students
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Level VI

Baldwin,
Johnson, Gotz,
Wayment, &
Elwell (2006).

Perspectives of
college students
and their primary
health care
providers on
substance abuse
screening

Exploratory
descriptive
Qualitative
Face to face
with focus
group
discussion

1. There are inconsistences in
substance abuse reported by the
college students and the knowledge
of their healthcare providers
regarding the extent of substance use
on college campus.
2.Differences of opinions about who
should bring up the topic of substance
abuse in a college health care setting:
• Providers recognized their
critical role in bringing up the
topic of substance abuse with
their patients and felt
responsible for creating an
atmosphere of trust.
• However, students prefer
substance abuse be addressed
by a psychologist or a
counselor since substance
abuse is a "mental issue.”
• Substance abuse only
becomes a doctor’s issue if it
is health-related, such as if
the provider is about to
prescribe medication or if the
patient is addicted to a
substance.
3. Difficulties in provider–patient
communication reported by the
healthcare provider and the student
groups.
• Providers stated
awkwardness in provider–
patient communication about
substance use.
• Students were concerned
about the confidentiality of
information disclosed during
an office visit and argued that
they are afraid of negative
judgment when disclosing a
substance-abuse problem to a
health-care provider in the
university environment
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Level VI

Barrett,
Darredeau,
Bordy, & Pihl
(2005).

Barrett,
Darredeau, Pihl
(2006)

Characteristics
of
Methylphenidate
Misuse in a
University
Student Sample.

Patterns of
Simultaneous
Polysubstance
use in drug using
university
students

Descriptive
study

•

Methylphenidate (MPH)
misusers reported using a
greater variety of substances
recreationally throughout
their lifetimes (mean 7.7, SD
3.0) relative to control
subjects (mean 3.8, SD 3.1)
{t = 5.98, df 98, P < 0.001).

•

Chi-square tests revealed that
MPH users were more likely
to report recreational use of
ecstasy, cocaine, ephedrine,
d-amphetamine, and
psilocybin (all Ps < 0.001)
than were control subjects.

•

Those who misused MPH
were more likely to have
used various other
prescription and
nonprescription stimulant
drugs over their lifetimes,
(mean 7.7, SD 3.0) relative to
control subjects (mean 3.8,
SD 3.1) {t = 5.98, df 98, P <
0.001).
The Chi-square tests showed
that MPH users were more
likely to report recreational
use of ecstasy, cocaine,
ephedrine, d-amphetamine,
and psilocybin (all Ps <
0.001) than were control
subjects
Chi-squared tests revealed
that when alcohol was used
in combination with any of
cannabis, psilocybin,
MDMA, cocaine,
amphetamine,
methylphenidate (ps<0.01) or
LSD (p<0.05) its initial use
preceded the administration
of the other substance.
Paired samples t-tests
revealed that when alcohol
was used with cocaine
(p<0.01) or methylphenidate
(p<0.05) it was ingested in

Structured
interviews

Qualitative
Descriptive
study

•

•

•
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Level VI

Level VI

greater quantities than when
used in their absence.
Bangert-Drowns
(1988)

The effects of
school-based
substance abuse
education

Meta-analysis

Drug-related knowledge;
Alcohol and drug education
successfully increased drug-related
knowledge, but was less successful in
changing attitudes, and least
successful in changing the drugrelated behaviors of students.
Knowledge: t(25) = 6.83, p < .001
Attitude, t(17) = 5.35, p < .001

Level I

The average effect size for
knowledge criteria was 0.76 standard
deviations;
attitude criteria: 0.34 standard
deviations;
Behavior criteria: 0.12 standard
deviations.
Only the knowledge and attitude
effects were large enough to be
reliably considered different from
zero.
The average effect for behavior was
not significantly different from zero, t
(13) = 1.23, p = .24.
•

Espada,
Gonzálvez,
Lloret, GuillénRiquelme,
Orgilés (2015)

Meta-analysis of
the effectiveness
of school
substance abuse
prevention
programs in
Spain.

Meta-analysis

Typical substance abuse
education (focus on
conventional alcohol and
drug prevention) had its most
positive effects on knowledge
and attitudes, but was
unsuccessful in changing the
drug-using behaviors of
students.

Oral and written substance abuse
prevention program information
together showed statistically
significant results (d= 0.69; P<.01).
The type of therapist implementing
the program explained part of the
variability as: the programs
implemented by professionals alone
(d= 0.25; p<.01) and those
implemented by professionals and
teachers together (d= 0.48; p<.01)

38

Level 1

showed remarkable differences in
effectiveness.
Fachini, Aliane,
Martinez, &
Furtado, (2012)

Efficacy of brief
alcohol
screening
intervention for
college students
(BASICS)

A metaanalysis of
randomized
controlled
trials.

Overall, brief intervention for college
students: (BASICS), delivered faceto-face lowered both alcohol
consumption and negative
consequences in college students.

Level I

At approximately 12 months, students
receiving BASICS had
a significant reduction in alcohol
consumption (difference between
means = −1.50 drinks per week, 95%
CI: -3.24 to −0.29) and
Alcohol-related problems (difference
between means = −0.87, 95% CI: 1.58 to −0.20) compared to controls.
On alcohol consumption: Q-statistics
= 32.61, 11 df, p < .01).
On alcohol related problems: Qstatistics = 21.38, 10 df, p = .02.

Ford, &
Schroeder,
(2009).

Academic strain
and non-medical
use of
prescription
stimulants
among college
students.

Descriptive
Correlational

Brief intervention used “according to
the principles of BASICS protocol or
very similar one:
(1) BI using techniques of
motivational interview and
personalized feedback,
(2) face-to-face intervention, and
(3) Comparison with other conditions
(such as control group or alternative
intervention).
There is no direct connection between Level IV
academic strain and stimulant use:
Students who experience higher
levels of academic strain should be
more likely to report the presence of
negative affect states.
In the structural model, academic
strain
is significantly associated with
depression (Beta ¼ .070), as
students under greater levels of
academic strain are more
likely to report higher levels of
depression than respondents
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who report lower levels of academic
strain
Students who report higher levels of
depression are more likely to report
the non-medical use of prescription
stimulants
Academic strain and depression in the
past year .070***
Academic strain and stimulant use in
the past year .001
Academic strain and depression in the
past 30days .192***
Academic Strain and stimulant use in
the past 30 days .002
(Standardized parameter estimate as
shown ***p < .001).

Foxcroft (2014)

Motivational
interviewing
(MI) for alcohol
misuse in young
adults.

Randomized
controlled trials

At four or more months follow-up,
effects were found for the quantity of
alcohol consumed (standardized
mean difference (SMD) 0.14; 95%
confidence interval (CI) -0.20 to 0.08 or a reduction from 13.7
drinks/week to 12.2 drinks/week),
Moderate quality of evidence;
frequency of alcohol consumption
(SMD -0.11; 95% CI -0.19 to -0.03 or
a reduction in the number of
days/week alcohol was consumed
from2.74 days to 2.57 days),
Moderate quality of evidence;
Peak blood alcohol concentration
(BAC) (SMD-0.14; 95%CI -0.23 to 0.05 or a decrease in peak BAC
from0.144%to 0.129%),
Moderate quality of evidence.
A marginal effect was found for
alcohol problems (SMD -0.08; 95%
CI -0.15 to 0.00 or a reduction in an
alcohol problems scale score from
8.91 to 8.18),
Low quality of evidence.
No effects were found for binge
drinking (SMD -0.05; 95% CI -0.12
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Level 1

to 0.01),
Moderate quality of evidence;
or average BAC (SMD -0.08; 95% CI
-0.22 to 0.06),
Moderate quality of evidence.
Other outcomes and at four or more
months follow-up we found no
effects on drink-driving (SMD -0.11;
95% CI -0.31 to 0.09),
Moderate quality of evidence;
or other alcohol-related risky
behavior (SMD -0.14; 95% CI -0.30
to 0.02),
Moderate quality of evidence.
Overall, no substantive, meaningful
benefits of interventions for the
prevention of alcohol Misuse
Statistically Significant effects are
not consistent for all misuse measures
Although some significant effects
were found, the effect sizes were
interpreted as too small, given the
measurement scales used in the
studies included in the review, to be
of relevance to policy or practice.

Herman,
Shtayermman,
Aksnes,
Anzalone,
Cormerais, &
Liodice (2011).

The Use of
Prescription
Stimulants to
Enhance
Academic
Performance
Among College
Students in
Health Care
Programs.

Moreover, the statistically significant
effects are not consistent for all
misuse measures, heterogeneity was a
problem in some analyses and bias
cannot be discounted as a potential
cause of these finding
Cross-sectional, Approximately 10.4% (32) of
descriptive, and students surveyed have either used a
associational
stimulant or are currently using
study
prescription stimulants illegally.
The most common reason for
stimulant use was to focus and
concentrate during studying (93.5%).
Of the 308 students, 45.2% were
female, 83.9% were Caucasian, and
amphetamine-dextroamphetamine
was the most commonly abused
stimulant (71.4%).
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Level VI

Demographic
Race/ethnicity:
Caucasians significant for nicotine
dependence, Alcohol abuse p<.05,
alcohol dependent p<.05, and drug
dependence p<.001
Male gender significant for alcohol
dependence p<.05
Female for nicotine dependence
p<.001
Asian demographic is significant for
stimulant dependent p< .001
Students in PA program also
significant for nicotine dependence
p< 0.001 compare to other
professions such as RN, DO, PT and
mental health counseling.
Female for stimulant dependent
Male for alcohol dependence p<.001

Recommended substance abuse and
awareness programs combined with
stress management programs in an
overall substance-abuse reduction
strategy, including the use of
prescription stimulant use beyond the
originally intended purpose.
Kazemi, Levine,
Dmochowski,
Nies, & Sun,
(2013).

Effects of
Motivational
Interviewing
Intervention on
Blackouts
Among College
Freshmen.

Experimental
Longitudinal
study

•

•

•

Larimer, M. E.,
& Cronce, J. M.

Identification,
prevention, and

•

Literature
Review
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Level III
The rate of blackouts
decreased from 40% at
baseline to 16% at six months
(p < .0001).
The average number, time,
and days of drinking and
frequency of drug use
decreased significantly (p <
.0001).
MI had an impact on
reducing alcohol
consumption and the rate of
blackouts among college
freshmen who were engaging
in high-risk drinking and
illicit drug use.
Level V
No support was found for
information/knowledge

(2007).

treatment
revisited:
individualfocused college
drinking
prevention
strategies 19992006.

Looby, De
Young, &
Earleywine,
(2013).

Challenging
expectancies to
prevent
nonmedical
prescription
stimulant use.

Mason, Deane,
Kelly, Peter, &
Crowe (2009).

Do Help in the
Management of
Cravings in
Substance Abuse
Treatment?

Randomized
Control Trials

approaches alone, or for brief
values clarification
approaches alone or with
other informational content.
• Evidence was found in
support of skills-based
interventions and
motivational interventions
that incorporated
personalized feedback, with
or without an in-person
intervention. Normative reeducation interventions
received mixed support
though personalized
normative feedback was
associated with positive
outcomes.
The expectancy challenge
successfully modified expectancies
related to prescription stimulant
effects.

Level 1

19% of the total sample reported
initiation of non-medical use of
prescription stimulant by follow-up.
Nearly all individuals who (17/18)
who reported non-medical use
attributed their use to cognitive
enhancement and study assistance
motivations.
Descriptive
Spirituality and self-efficacy have
Level VI
Cross -sectional significant relationships with cravings
study with
interview
Self-efficacy mediated the
relationship between spirituality and
drug and/or alcohol cravings
There were positive correlations
found between spirituality and selfefficacy
(r = .33) and spirituality and
religiosity (r = .69).

Spirituality has a significant
influence on “cravings”
(β =–.33, p =.04).
A statistically significant inverse
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relationship was found between
“cravings” and spirituality (r = –.30)
No significant effect for the influence
of religiosity on “cravings” (β = .05,
p = .75).
Self-efficacy had a significant
influence on “cravings” (β = –.34, p
= .01)
Self-efficacy was negatively
correlated with “cravings”
(r = –.42).
The R2 suggests that spirituality and
religion account for 8.9% of the
variance in “cravings.”

McCabe & Teter
(2007)

Drug use related
problems among
nonmedical
users of
prescription
stimulants:

Descriptive
Qualitative

Increase in simultaneous poly-drug
use occurs among college students
with NMUPS than other drug users
(53.8% versus 16.9%, p<0.001)
Past year medical users of
prescription stimulants will
experience blackouts as a result of
drug use (21.7% versus 8.3%,
p<0.001), engaged in illegal activities
to obtain drugs (27.4% versus 9.3%,
p<0.001), and experienced
withdrawal symptoms when they
stopped taking drugs (14.6% versus
2.5%, p<0.001) than other drug users.
The frequency of (nonmedical use
prescription stimulants) NMUPS was
associated with drug use related
problems based on the (Drug Abuse
Screen Test (DAST-10).
Among past-year non- medical users
of prescription stimulants (n=212),
experiencing three or more DAST-10
items was reported by 42.2% of those
who used on 1 to 2 occasions,
58.2% (3 to 5 occasions),
58.3% (6 to 9occasions),
and76.3% of those who used on 10 or
more occasions (χ2 =12.9, df=3,
p<0.01).
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Level IV

Redman (2008).

Stressful life
experiences and
the roles of
spirituality
among people
with a history of
substance abuse
and
incarceration.

Majority of nonmedical users of
prescription stimulants are polydrug
users and should be screened for
potential drug abuse or dependence,
especially those who report non-oral
routes of administration.
Eight themes emerged from the study
regarding the roles that spirituality
played in the study participants’ lives,
including utilizing spirituality to:
1. Seek a context for adversity
in order to better cope with
its impact; described
combing through religious
and spiritual texts for
passages that might help
them understand and cope
with the anguish they had
experienced.
2. Using a spiritual framework
to understand one’s own true
nature: These men and
women reported reading
spiritual tracts, seeking
guidance from religious or
spiritual leaders, praying for
answers, meditating, or
engaging in other spiritual
practices in an effort to gain
greater perspective on their
authentic selves.
Approximately 20% of the
respondents asserted that
accessing explicit spiritual
guidance seemed preferable
to traditional mental healthrelated therapy or counseling
3. Seek redemption for past
transgressions; more than
90% of the respondents
expressed remorse over the
harm they had inflicted
through negligence, anger, or
exploitation. They voiced the
hope that a divine being
might be able to redeem them
for the pain they had
engendered.
4. Redeem, care for, or liberate
others; One- third expressed

Qualitative
Descriptive
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Level IV

5.

6.

7.

8.
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a more generalized wish to
allow God or some
transcendent spirit to work
through them in acts of
kindness, compassion, and
caring for others.
repay the debt of having
one’s life saved by divine
intervention; A quarter of the
respondents posited that,
after facing one potentially
fatal situation after another,
their lives had been spared by
divine intervention, and they
needed to repay that debt.
Develop a relationship with a
divine entity as human beings
have proven untrustworthy;
Nineteen percent of the
respondents utilizing
spirituality as a shaping force
in their lives explained that,
subsequent to the many
disappointments and
betrayals they had endured at
the hands of others, God was
all they could count on. And,
deepening their relationships
with God would provide the
intimacy and trust that was
lacking in their connection
with other human beings.
Utilizing spirituality to
modify the use of drugs and
or alcohol; More than half of
the respondents associated
spirituality with abstinence or
a modification of substance
use and some link abstinence
with relationship with God
and
Transform one’s character:
turned to God for assistance
in changing his attitudes
about himself and others:
About 36 % articulated the
theme of spirituality as a
route to self- transformation.
They hope that based on the
changes wrought with God’s
assistance, they would lead a

more positive and productive
life.
Sarkar,
Balachander, &
Basu (2014).

Perceived
Harmfulness of
Substance Use

Descriptive
Qualitative

Greater degree of education was
associated with lower harm rankings
for
heroin, cannabis,
dextropropoxyphene, and raw opium

Level VI

Urban residence was associated with
greater harm ratings for cannabis and
raw opium.
Differences in the harms were
perceived for different preparations
of the same active compound for
alcohol and nicotine.

Saitz, Barrio, &
Miquel (2014).

Screening and
brief
intervention
(SBI) for
Unhealthy drug
use: little or no
efficacy.

Spoth, Trudeau, Universal
Guyll, Shin, &
Intervention
Redmond (2009) Effects on
Substance Use
Among Young
Adults Mediated
by Delayed
Adolescent
Substance
Initiation

Literature
Review

Experimental
longitudinal
study

Harm ratings of substances can be a
useful guide while formulating
policies and allocating resources.
• Evidence now suggests that
efficacy is limited or nonexistent.
• Brief intervention may have
some efficacy for unhealthy
drug users seeking help.
• The model of SBI that has
effects in primary care
settings on risky alcohol use
may not be efficacious for
other drug use
Universal family focused
intervention: Iowa Strengthening
Family program (ISFP) and Preparing
for the Drug-Free Years (PDFY)
were implemented

There is a significant (p< .05) Iowa
Strengthening Family program (ISFP)
direct effects on drunkenness
frequency and the Polysubstance Use
Index, and a marginally significant
(p<.10) ISFP direct effect on cigarette
frequency.
There is a significant direct Preparing
for the Drug-Free Years (PDFY)
effects on cigarette frequency and
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Level V

Level III

alcohol-related problems (p<.05).
Initiating Universal family-focused
interventions (ISFP and PDFY:
prevention programs) for delayed
substance use during adolescence can
reduce problematic substance use
during young adulthood

Relative reduction rates (RRR)
ranged from 19% to 31% for ISFP
and from 9% to 16% for PDFY

Spoth, Trudeau,
Shin, Ralston,
Redmond,
Greenberg, &
Feinberg, (2013)

Longitudinal
Effects of
Universal
Preventive
Intervention
on Prescription
Drug Misuse
With Late
Adolescents and
Young Adults

Randomized
Controlled
Trials (RCT) to
evaluate Iowa
Strengthening
Families
program (SFP)
for parents and
youth 10-14
years (SFP 1014) and Life
Skill Training
(LST)

Treloar,
Dubreuil, &
Miranda JR.,
(2014)

Spirituality and
Treatment of
Addictive
Disorders.

Experts
opinions

48

Early intervention of substance abuse
prevention program such as universal
intervention may reduce substance
abuse during young adulthood.
Study One
The Iowa SFP reduces prescription
opioid misuse (POM) and
prescription drug misuse overall
(PDMO).
(Relative reduction rates (RRR): age
25 years of 65%, and comparable
benefits for higher and lower risk
subgroups
Study Two
The IOWA SFP 10–14 + LST
showed significant or marginally
significant effects on POM and
PDMO across all ages (21, 22, and 25
years); higher-risk participants
showed stronger effects (RRRs =
32%–79%)
Study 3
Shows significant results for POM
and PDMO (12th grade RRRs =
20%–21%); higher-risk and lowerrisk participants showed comparable
outcomes.
Since multicultural competence can
increase the ability of health care
providers to work effectively with
culturally diverse populations,
spiritual competence among health
care providers may enhance their
effectiveness when working with
individuals struggling with
addictions.

Level 1

Level VII

Effective interventions such as
Motivational Interviewing and
Acceptance and Commitment
Therapy acknowledge the importance
of the provider’s ability to allow a
creation of an open, non-judgmental
and compassionate environment.
When working in the area of
addiction treatment, spiritual
competence may increase the ability
of the provider to help the client to
discover or rediscover their own
purpose and core values, explore the
negative consequences of the
addictive behavior on these values,
and to develop behaviors that support
the identified core values.
If the provider has not considered his
or her own spiritual competence, or
moreover, holds the view that
spiritual competence is not important
for treatment, he or she may be less
able to recognize or attend to the
client’s needs or perspectives.

Spirituality plays a vital role in the
development and recovery of
addictive disorders. However, health
care professionals need Spiritual
competences.

Weyandt, Oster,
Marraccini,
Gudmundsdottir
Munro,
Martinez
Zavras, & Kuhar
(2014).

Pharmacological
interventions for
Pharmacology
intervention for
adolescents and
adults with
ADHD:
stimulant and
non-stimulant
medications and
misuse of
prescription
stimulants.

•

Systematic
Review

•
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Both prostimulant and
stimulant medications, such
as lisdexamfetamine
dimesylate, methylphenidate,
amphetamines, and mixedamphetamine salts, are
effective in reducing ADHD
symptoms in adolescents and
adults with ADHD.
Individuals with ADHD may
have higher rates of stimulant
misuse than individuals

Level II

without the disorder.
Characteristics such as sex,
race, use of illicit drugs, and
academic performance are
associated with misuse of
stimulant medications.
• Individuals both with and
without ADHD are more
likely to misuse short-acting
agents than long-acting
agents.
Insufficient evidence exists as to
whether BIs, as part of SBIRT, are
effective or ineffective for reducing
the use of, or harms associated with
nonmedical use of, psychoactive
substances when these interventions
are administered to non -treatmentseeking, screen-detected populations.
•

Young, Stevens,
Galipeau, Pirie,
Garritty, Singh,
Yazdi, Golfam,
Pratt, Turner,
Porath,-waller,
Arratoon, Haley,
Leslie, Reardon,
Sproule,
Grimshaw,
Moher (2014).

Effectiveness of
brief
interventions as
part of the
Screening, Brief
Intervention and
Referral to
Treatment
(SBIRT) model
for reducing the
nonmedical use
of psychoactive
substances:

Systematic
review

Level I

Summary of Findings
Strengths of evidence. A summary of the levels of evidence of the 26 articles is
presented in Table 3. The strength of the research evidences of these studies ranges from level I
to level VII. The most commonly used research designs were systematic review/meta-analysis
or single descriptive/qualitative studies. Eight studies were level I (systematic review or metaanalysis of all relevant RCTs) (30.8%) and eight studies were level VI (30.8-%). Another
common research findings in the project are level III (7.7%), level IV (7.7%) and level VII
(7.7%). The rest of the research designs also include level IV (11.5%) and level II (3.8%). The
longitudinal studies in this project revealed the effect of early substance abuse prevention
program which was initiated during early adolescent’s stage to monitor the participants’
behaviors towards substance abuse through young adulthood (Spoth, Trudeau, Guyll et al., 2009;
Spoth, Trudeau, Shin et al., 2013). Spoth, Trudeau, Shin et al. (2013) research study shows the
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effect of universal prevention intervention initiated during early adolescents, and participants’
behavior towards substance abuse was monitored through late adolescents, college and young
adulthood. One of the expert opinions research designs (level VII) addressed spirituality in
relation to substance disorders while the other design from the American college Health
recognized the need and suggested ways to manage the problems of increasing prescription
stimulant abuse among all students including high schools’.
Table 3:Summary: Levels of Evidence
Level
Types of Evidence
Level I
Level II
Level III
Level IV
Level V
Level VI
Level VII

Evidence from a systematic review or metaanalysis of all relevant RCTs
Evidence obtained from well-designed RCTs
Evidence obtained from well-designed controlled
trials without randomization
Evidence from well-designed case-control and
cohort studies
Evidence from systematic reviews of descriptive
and qualitative studies
Evidence from single descriptive or qualitative
studies
Evidence from the opinion of authorities and/or
reports of expert committees

Number/Percentage of
Studies in This Project
8 (30.8%)
1 (3.8%)
2 (7.7%)
3 (11.5%)
2 (7.7%)
8 (30.8%)
2 (7.7%)

Note. Adapted from Evidence-based practice in nursing and healthcare: A guide to best practice, by Melnyk, B.M.
& Fineout-Overholt, E., 2011, Philadelphia: Lippincott, Williams & Wilkins.

General findings about PSA. Despite being the most widely misused prescription drugs
among college students, prescriptions stimulants have been accepted as non-dangerous as long as
they are dispensed as ordered, used as prescribed, and closely monitored by licensed
professionals (Agency for Health care Research and Quality, 2013; Weyandt et al., 2014).
Nevertheless, individuals both with and without ADHD symptoms who use prescription
stimulants such as Adderall, Ritalin, Concerta, and Vyvanse have been revealed as more likely to
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misuse the stimulants (Weyandt et al., 2014). Furthermore, college students’ perception of
prescription stimulants “as opposed to illegal stimulants (cocaine and methamphetamine) as
“safer and pure choices” for experimentation and getting high puts them at a higher risk for
stimulant abuse than any populations (Cutler, 2014, p. 278; Herman et al., 2011). McCabe,
Knight, Teter et al. (2005) revealed the lifetime prevalence of prescription stimulant use in 2001
among college students as 6.9-percent with higher rate among colleges located in the northeastern region of the US and colleges with more competitive admission standards. In addition,
the result of the survey conducted by McCabe, West and colleagues in 2014, revealed the past
year illegal use of stimulants among college students has a significant increase from 5.4% in
2003 to 9.3% in 2013 (p<0.001). The result of the survey also disclosed approximately one in
every five individuals reported non-medical use of at least one prescription medication class in
their lifetime. The probabilities of non-medical use of each prescription medication class were
generally greater among males, Whites, members of social fraternities and sororities, and those
with a lifetime history of medical use of prescription medications or a past-year history of being
approached to divert their prescription medications (McCabe, Knight, Teter et al., 2005 &
McCabe, West, Teter et al., 2014). Therefore, the increase in awareness and education with
prescription stimulant abuse competence for the providers and college students are very crucial
to the management of PSA among college students.
Most college students are unaware of the dangers associated with the use of prescription
stimulants without the supervision of a license health care provider (Arria et al., 2008; Baldwin
et al., 2006). One of the problems associated with PSA or any psycho-stimulant abuse is the
problem of poly-substance abuse which increases with prescription stimulant use and abuse
(Barrett, Darredeau, Bordy et al, 2005; Barrett, Darredeau, Pihl, 2006). Several studies have
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revealed alcohol, nicotine and marijuana as access drugs to other psycho-stimulant abuse
(Barrett, Darredeau, Pihl, 2006; DeSantis, Webb et al., 2008; DeSantis, Noar et al, 2010;
Johnston et al, 2013). At the same time, the risk of misusing prescription stimulants increases
with college students who smoke and abuse alcohol than other drug users. A study by McCabe
& Teter, 2007) revealed increase in simultaneous poly-drug use occurs among college students
with NMUPS than other drug users (53.8% versus 16.9%, p<0.001) (McCabe & Teter, 2007).
The increasing number of students who abuse prescription stimulant suggest lack of awareness
and education about the dangers and health related consequences of PSA. Therefore, increasing
perceived harmfulness through awareness and education has been suggested as a possible
prevention strategy for most college students (Agency for Health care research and Quality,
2013; American College Health, 2007; Arria et al., 2008; Baldwin et al., 2006; Bangert-Drowns,
2014; Herman et al., 2011; Sarkar et al., 2014). In 2011, Herman and colleagues’s study also
revealed the impact of academic stress among college students who abuse prescription
stimulants. The study revealed approximately 10.4-percent of the students surveyed have either
used a stimulant or are currently using prescription stimulants illegally. The most common
reason for stimulant use was to focus and concentrate during studying (93.5%). Of the 308
students, 45.2% were female, 83.9% were Caucasian, and amphetamine-dextroamphetamine was
the most commonly abused stimulant (71.4%). Moreover, ineffective coping skills with life
events and academic enhancement are among the motives identified by some college students.
DeSantis, Webb, & Noar (2008), survey shows most students who are unable to cope with the
workload of college use stimulants for academic performance enhancement. However, the study
by Mason et al (2009) showed self-efficacy- a mediator between spirituality and drug/or alcohol
cravings as part of stress management reduction program. According to Bandura, (1986), self-
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efficacy is defined as an individual’s belief that he or she can successfully manage or cope with
difficult situations. Therefore, several studies have recommended stress management programs
in an overall substance-abuse reduction strategy including the use of prescription stimulant abuse
(Herman et al., 2011; Mason et al., 2009; Redman, 2008).
Interventions/management. Four studies investigated effectiveness of universal
prevention interventions programs for general substance abuse such as school based and
community based substance prevention program (Banger-Drowns, 1988; Espada, 2015; Spoth,
Trudeau et al., 2009; Spoth, Trudeau, Shin, Ralston et al., 2013). The key aspects of the findings
in this project are:
•

Collaborative approach of interventions (such as community university collaboration)
(Baldwin et al., 2008; Espada et al., 2015). Research findings suggested
collaboration between healthcare providers and the community such as schools in
implementing overall substance abuse prevention program.Family involvement
intervention (Spoth, Trudeau et al., 2009; Spoth, Trudeau, Shin, Ralston et al., 2013).

•

Studies have shown the effectiveness of universal preventive intervention program
such as family-focused and school-based interventions in the management of youth
risk-taking behaviors such as alcohol abuse and other substance abuse behavior
problems (Spoth, Guyll, Trudeau et al., 2002; Spoth, Trudeau, Guyll, Shin et al.,
2009; Spoth, Trudeau, Shin, Ralston et al., 2013). Family strengthening program has
been suggested as the treatment with the strongest evidence of relative effectiveness
(Level 1 evidence). Family therapy programs were found to be more effective than
their comparison conditions and, no treatment programs were less effective. In
addition, the longitudinal study by Spoth, Trudeau et al. (2014) revealed all types of
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treatment such as the Preparing for Drug Free Year (PDFY) and Iowa Strengthening
Family Program (ISFP) showed reductions in substance use and the greatest
improvements were found for family therapy and mixed and group counseling.
Moreover, the result of Spoth, Trudeau, Guyill et al (2009) showed a significant ( p<
.05) Iowa Strengthening Family program (ISFP) direct effects on drunkenness
frequency and the polysubstance use index, and a marginally significant (p<.10) ISFP
direct effect on cigarette frequency and alcohol-related problems (p<.05).
Significance of raising awareness through educational/training/screening programs (Agency
for Healthcare Research and Quality, 2013; Arria et al., 2008; American college Health, 2007;
Amaro, 2010; Barrett, Darredeau, Pihl, 2006; Barrett, Darredeau, Bordy et al., 2005; Foxcroft,
2014; Kazemi, et al., 2013; Larimer et al., 2007; McCabe & Teter, 2007; Sarkar et al., 2014;
Saitz et al., 2014; Young et al., 2014). The research findings from Arria and colleagues (2008)
revealed awareness through education as one of the most crucial ways to manage prescription
stimulants abuse among college students. Baldwin and colleagues study revealed most providers
lack of awareness of the prevalence of misuse of prescription drugs especially prescription
stimulants among the college students. Healthcare providers caring for college students with
prescription stimulants need to improve continuously in substance abuse management
competency (Baldwin et al., 2006; Agency for Healthcare Research and Quality, 2013).
Likewise, college students need to be educated on the prescription medication they are using
(Baldwin et al., 2006; Agency for Healthcare Research and Quality, 2013).
Spirituality: The expert opinion regarding spirituality in the management of overall
substance abuse should not be ignored (Treloar et al, 2014). Spiritual competence has been
suggested for health care providers to improve their Spirituality and provide effective
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substance abuse intervention programs while working with individuals struggling with
addictions (Treloar, 2014). Redman (2008) study shows the meaning of Spirituality is
different with individuals. However, developing Spiritual competence may assist the health
care providers to be sensitive, recognize and attend to the underlying problems and needs of
the patients with addiction (Redman, 2008). Treloar (2014) concluded that Spirituality plays
a vital role in the growth and recovery of addictive disorders. However, health care
professionals need Spiritual competences.
Evidence-Based Recommendations
Strong Recommendations (GRADE A)
1. The primary health care provider should pursue increase in knowledge/ awareness with
periodic education and training regarding prescription stimulants to ensure proper and
safe prescription stimulant use and reduce diversion among college students (Level I:
Agency for Healthcare Research and Quality, 2013; Arrial et al., 2008; BangertDrowns, 1988; Espada et al., 2015; Level VI: Baldwin et al., 2006).
2. The health care provider should initiate substance abuse prevention in primary care that
includes brief screening, and motivational intervention. A necessity for feedbacks and
subsequent follow-ups should also be communicated to the college students (Level VI:
Amaro, 2010; Level 1: Fachini et al. 2012; Level V: Kazemi et el., 2013).
3. The health care provider should provide comprehensive information including major
health-related harmful effects of prescription stimulant abuse to college student with
ADHD symptoms who requires the use of prescription stimulants (Level IV: Arria et
al., 2008; Level IV: Barrett, Darredeau, Pihl., 2006; MCabe et al., 2007).
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4. The health care provider should provide information regarding poly-substance abuse
for college students who use prescription stimulant. Moreover, the healthcare provider
should consider screening college students with prescription stimulant for polysubstance abuse (Level IV: Barrett, Darredeau, Bordy et al., 2005; Barrett, Darredeau,
Pihl, 2006; McCabe, West, Morales et al., 2007).
5. The health care providers should encourage parents of college students to take a
primary role in understanding the need for family involvement in the prevention of
nonmedical use of prescription stimulants (Level of evidence VI: Spoth, Trudeau et al.,
2009; Level I: Spoth, Trudeau, Shin et al., 2013).
6. The health care providers should work with college student campus administrations to
implement appropriate school-based substance prevention program and develop a
multidisciplinary campus action plans and community collaboration to reduce
nonmedical prescription stimulant use as was implemented with smoking and other
illicit drugs (Level of Evidence VI: Baldwin et al., 2006; Level of Evidence 1: Espada,
2015).
Weak Recommendation (GRADE B)
1. The health care provider may consider offering spiritual support programs as substance
abuse prevention program based on college students' cultures and beliefs ( Level IV:
Mason et al., 2009: Level VII: Redman, 2008; Treloar et al., 2014).
2. The health care provider may provide awareness programs combined with stress
management programs in an overall substance-abuse reduction strategy, including the use
of prescription stimulant beyond the originally intended purpose (Level of Evidence IV:
Ford et al., 2009; Level VI Herman et al., 2011)
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Chapter 5: Discussion
College students have been identified as one of the populations with a tendency to abuse
prescription stimulants. Evidence-based recommendations were developed in this project to
assist healthcare providers in the management of PSA among college students. These
recommendations will serve as a guiding tool when caring for college students with ADHD, or
college students with potential for prescription stimulant abuse. Moreover, these
recommendations may be used in primary care settings that care for college students or young
adults with a history of prescription stimulant/substance abuse and contemplate on quitting.
Gough (2001) stated a change implemented by front-lines practitioners such as primary care
providers is more successful than the one initiated by the management. Health care providers
occupy several roles in the society such as a teacher, mentor, and guardian. Understanding the
importance of managing prescription stimulant abuse to make positive changes that may lower
the prevalence of PSA is crucial to health care provider’s role. Initiating substance prevention
interventions such as awareness, family strengthening among others earlier in life before
attending college may be more beneficial in reducing the tendency to engage in PSA later in life.
Nevertheless, providing awareness and education for college students and family regarding the
prevalence of subsance abuse in general is crucial to reducing prescription stimulant abuse
among college students (Arria et al., 2008: Agency or Healthcare Research and Quality, 2013;
Bangert-Drown, 1988) ( also see Appendix). At the same time, healthcare providers must be
knowledgeable, experienced and comfortable to address the issues which surround PSA among
college students (Baldwin, 2006).
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